CL2018002646A1 - Prevención de la adherencia del tejido biológico. - Google Patents

Prevención de la adherencia del tejido biológico.

Info

Publication number
CL2018002646A1
CL2018002646A1 CL2018002646A CL2018002646A CL2018002646A1 CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1 CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1
Authority
CL
Chile
Prior art keywords
biological tissue
adhesion
self
prevention
assembling peptide
Prior art date
Application number
CL2018002646A
Other languages
English (en)
Inventor
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of CL2018002646A1 publication Critical patent/CL2018002646A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En la presente se describen métodos y materiales para mitigar la adherencia de tejidos biológicos. Un método para mitigar la adherencia a un tejido biológico incluye administrar una cantidad efectiva de una solución de péptido autoensamblante al tejido biológico, en donde el péptido autoensamblante tiene entre 7 aminoácidos y 32 aminoácidos de longitud, y la solución de péptido autoensamblante forma un hidrogel en condiciones fisiológicas.
CL2018002646A 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico. CL2018002646A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18

Publications (1)

Publication Number Publication Date
CL2018002646A1 true CL2018002646A1 (es) 2019-07-05

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002646A CL2018002646A1 (es) 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico.

Country Status (11)

Country Link
US (3) US20190091376A1 (es)
EP (1) EP3429653B1 (es)
JP (1) JP7049557B2 (es)
KR (1) KR20190022455A (es)
CN (1) CN109152868A (es)
AU (2) AU2017232540A1 (es)
BR (1) BR112018068941A2 (es)
CA (1) CA3017684A1 (es)
CL (1) CL2018002646A1 (es)
MX (1) MX2018011121A (es)
WO (1) WO2017158420A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112368295A (zh) 2018-07-03 2021-02-12 立美基股份有限公司 离子性自组装肽
JP7335025B2 (ja) 2020-03-31 2023-08-29 株式会社スリー・ディー・マトリックス 照射による自己組織化ペプチドの滅菌

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4049671A1 (en) * 2004-07-06 2022-08-31 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
EP1879606B1 (en) * 2005-04-25 2013-06-12 Massachusetts Institute of Technology Self-assembling peptides for promoting hemostasis
BRPI0920030B1 (pt) * 2008-10-06 2019-03-26 3-D Matrix, Ltd. Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal
EP2750687B1 (en) * 2011-09-02 2017-12-06 3-D Matrix, Ltd. Amphiphilic peptides for thoracic air leakage occlusion
JP2016501066A (ja) * 2012-11-14 2016-01-18 株式会社スリー・ディー・マトリックス 血管塞栓システム
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage

Also Published As

Publication number Publication date
KR20190022455A (ko) 2019-03-06
CA3017684A1 (en) 2017-09-21
JP7049557B2 (ja) 2022-04-07
AU2021225225A1 (en) 2021-09-30
JP2019508184A (ja) 2019-03-28
WO2017158420A1 (en) 2017-09-21
BR112018068941A2 (pt) 2019-04-16
CN109152868A (zh) 2019-01-04
US20220111126A1 (en) 2022-04-14
AU2017232540A1 (en) 2018-09-27
US20230241294A1 (en) 2023-08-03
US20190091376A1 (en) 2019-03-28
EP3429653B1 (en) 2022-11-09
MX2018011121A (es) 2019-01-31
EP3429653A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
CL2016001405A1 (es) A peptide mixture
CL2018002644A1 (es) Oclusión fístula pancreática.
CL2020000382A1 (es) Composiciones de aminoácidos para el tratamiento de enfermedad hepática.
PE20200748A1 (es) Composiciones de aminoacidos para el tratamiento de lesion neuronal
PE20140190A1 (es) Moduladores de proteinas notum y metodos de uso
CL2018002646A1 (es) Prevención de la adherencia del tejido biológico.
ES2421915T3 (es) Derivados de amida del ácido hialurónico en osteoartrosis
CO2019006341A2 (es) Fragmento fab novedoso de anticuerpo anti-muc1 de humano
CY1120642T1 (el) Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση
CY1117854T1 (el) Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση
PE20160012A1 (es) Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral
GB2558315A (en) Patterned surfaces
CO2019009000A2 (es) Combinaciones farmacéuticas para tratar cáncer
CL2021000129A1 (es) Apirasas solubilizadas, métodos y usos
BR112017015613A2 (pt) gel intestinal de levodopa e carbidopa e métodos de utilização
MX2022014577A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
CL2018001470A1 (es) Vacunación con el dominio alfa 3 de mica/b para el tratamiento del cáncer
WO2014045065A3 (en) Dietary compositions and their uses
CL2018002643A1 (es) Oclusión de fuga de líquido cefalorraquideo.
ES2722803T3 (es) Fármaco que contiene lectinas de muérdago recombinantes para el tratamiento del melanoma maligno
CL2019001570A1 (es) Uña postiza y un método para su conformación sobre una uña natural.
PE20180127A1 (es) Composicion cosmetica reductiva de aplicacion topica que contiene queratina y azufre
CY1119117T1 (el) Δερμοπροστατευτικη και δερμο-εξισορροπητικη συνθεση
CO2022010207A2 (es) Uso de derivados del ácido hialurónico en la regeneración de tejidos óseos y cartilaginosos
FR3029104B1 (fr) Utilisation d'esters de alpha,omega-diols et de derives n-acyles d'acides amines comme agent de brunissage et/ou de bronzage de la peau humaine